Group 1: Investor Relations Activity - The investor relations activity involved a specific audience survey with a total of 9 investors participating [2] - The event took place on December 24, 2025, in the headquarters meeting room [2] - The company representatives included the securities affairs representative, Rong Huan [2] Group 2: Discussion Topics - Investors engaged in discussions regarding the company's brand matrix, national treasures, product structure, product research and development, and terminal sales conditions [2] - A tour of the company exhibition hall was conducted during the event [2] Group 3: Compliance and Disclosure - The company adhered to the "Information Disclosure Management System" regulations, ensuring that information disclosed was true, accurate, complete, timely, and fair [2] - No significant undisclosed information leakage occurred during the reception process [2] - Investors participating in the on-site survey signed a commitment letter as required by the Shenzhen Stock Exchange [2]

Group 1: Company Overview and International Strategy - The company has successfully implemented an internationalization strategy, with operations in over 70 countries and regions, leading to an increasing share of overseas business revenue [2][3] - Recent entry into the data center power generation sector aims to enhance global development and diversify overseas business structures [2] - Continuous collaboration among various business segments in overseas markets has resulted in new breakthroughs and increased demand for high-end equipment [2][3] Group 2: Natural Gas Business Growth - The rapid growth in natural gas orders is attributed to the restructuring of global supply patterns and the increasing importance of natural gas for energy security [4] - The demand for clean energy has risen, positioning natural gas as a strategic bridge in the global energy transition [4] - The company has established a comprehensive natural gas solution capability, gaining customer recognition and a strong market reputation [4] Group 3: Data Center Power Generation Sector - The company’s power generation equipment meets high standards for reliability and flexibility required in data centers and industrial applications [5] - Establishment of the Jerry Min Electric Energy Group aims to accelerate breakthroughs in the power generation sector [5] - Successful sales and leasing of gas turbine generator sets in North America have built a solid brand reputation for the company [5] Group 4: Future Outlook for Power Generation Business - The company plans to deepen its focus on data centers, industrial energy, and new power systems through continuous technological innovation and product iteration [7] - Aiming to provide integrated solutions for power equipment supply, intelligent operation control, and lifecycle maintenance support [7] - The goal is to enhance reliable power support capabilities from energy production to electricity assurance [7]

证券代码：001287 证券简称：中电港 | | √特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 ☐业绩说明会 | | 投资者关系活动类别 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | | 兴业基金 牟方晓 | | 活动参与人员 | 前海人寿保险 丁超凡 | | | 泽铭投资 单河 | | | 方正证券 金晶 | | 时间 | 2025年12月24日下午13:30-14:30 | | 地点 | 公司会议室 | | 形式 线下 | | | 上市公司接待人员姓名 | 证券事务代表 谢日增 | | | 投资者关系专员 邓丽婷 | | 交流内容及具体问答记录 | 首先向投资者介绍了公司所处行业情况、主要业务以及经营情 1、请问公司是英伟达产品的代理商吗？主要产品和应用领域 | | | 况，并就投资者关注的问题进行了交流，主要内容包括： | | | 是什么？ | | | 公司是英伟达的国内授权分销商之一，目前主要授权分销用于 | | | 数据中心的GPU、Jetson系列产品以及自动驾驶方面的汽车芯片等。 | | | 2、公 ...

Group 1: Small Nucleic Acid Business - The company’s small nucleic acid business primarily involves phosphoramidite monomers and GalNAc delivery systems, with delivery systems priced higher than monomers [2] - The company has delivered part of its small nucleic acid business orders and will continue to meet customer needs, with further details available in future reports [2] - The company possesses a stable and effective quality system, necessary production equipment and technology, smooth supply chain responsiveness, and compliance advantages to become a supplier for multinational corporations (MNCs) [2][3] Group 2: Production Capacity and Main Business - The company’s fundraising projects are gradually releasing production capacity to meet diverse customer orders [3] - The main business includes providing key pharmaceutical intermediates, active pharmaceutical ingredients (APIs), CDMO services, L-carnitine series products, and stem cell drug development [3] - The company is focused on continuous innovation in new products and processes to expand product depth and breadth, aiming for a richer customer structure [3] Group 3: Stem Cell Project Progress - The company has completed the design, installation, debugging, and confirmation of GMP facilities for its cell therapy projects, including myocardial infarction and cerebral infarction [3] - Technical transfers for the isolation, culture, and cryopreservation of umbilical cord mesenchymal stem cells have been completed, establishing seed, master, and working cell banks [3] - The company has developed and validated analytical methods and initiated process validation in preparation for IND application [3] Group 4: Disclosure of Major Information - The activity did not involve the disclosure of any undisclosed major information [3]

Group 1: Financial Performance - The semiconductor and related businesses achieved revenue of 55.4 million yuan in the first three quarters of 2025, representing an 85% year-on-year increase [2] - Revenue from semiconductor photolithography and testing services reached 17.7 million yuan, with a growth of over 110% [2] - PCB business revenue exceeded 30 million yuan, showing a growth of over 200% [2] Group 2: Business Growth Drivers - The growth in revenue is primarily driven by increased product delivery volumes from existing customers [3] - The company is focusing on high-precision optical processing and testing equipment to meet market demands in the semiconductor sector [3] - The company has initiated the installation of new high-precision equipment, with some expected to be operational by mid-2026 [3] Group 3: Future Business Prospects - The semiconductor and related businesses are strategic priorities, with plans for continued resource investment to maintain growth [4] - The laser business, while growing at a slower pace, is expected to remain stable and contribute to the company's overall performance [4] - The infrared optics business has shown recovery, driven by market demand for smaller, lighter products in various applications [5] Group 4: International Expansion - The company maintains a "domestic + international" dual-drive strategy, with a wholly-owned subsidiary in Singapore and plans for a new subsidiary in Malaysia [6] - The international business has faced revenue declines due to fluctuations in the global trade environment [6] - The Malaysian subsidiary is expected to enhance the company's international operations and create new growth opportunities [6]

Group 1: Acquisition and Product Development - The acquired asset group is expected to support a product sales volume of approximately 4 million units this year, with sufficient capacity from the production partner, Xuchang Future [1] - The Multi-Micro (III) product is currently under technical review and is expected to be approved next year, targeting children weighing ≥15kg and adult patients [1] - A one-time payment of 6 million yuan will be made upon the approval and change of the marketing authorization holder for Multi-Micro (III) [2] Group 2: Health Products and Market Strategy - The company's health products are in the R&D optimization and commercialization phase, with a planned launch next year, depending on R&D progress and sales channel development [2] - The health products will primarily utilize online sales, separate from the existing pharmaceutical sales team, leveraging the company's unique raw material advantages [2] Group 3: Traditional Chinese Medicine (TCM) Business Stability - The TCM decoction pieces business is stable, with a strong brand presence established in Zhejiang province, particularly in Hangzhou and Huzhou [2] - The impact of centralized procurement on the TCM formula granules business is limited, as the company primarily operates within the province [2] Group 4: Fundraising and Investment Projects - The planned fundraising through convertible bonds aims to raise approximately 1 billion yuan, focusing on core capacity upgrades and R&D enhancements [2] - About 1 billion yuan is allocated for the construction of an intelligent TCM health factory, with an estimated construction period of 2-3 years [2]

Group 1: Company Overview - The company primarily engages in the development, production, and sales of automotive motor technology and fluid technology products, aiming to become a global leader in automotive motor technology solutions [2][3] - The main production base is located in Ningbo, with additional production facilities in Qingyuan, Shenyang, Wuhan, the USA, and Thailand to serve clients more effectively [3] Group 2: Research and Development - The company is enhancing R&D investments in humanoid robots and industrial automation, focusing on harmonic magnetic field motor technology and new magnetic materials, which are key future development areas [4] - The company has achieved several technological breakthroughs and obtained relevant patents in these new fields [4] Group 3: Thailand Factory Development - The first phase of the Thailand factory is focused on producing cleaning pumps and motors, with plans to expand to more complex components like active perception cleaning systems and thermal management systems in the second phase [5] - The factory is expected to provide new growth momentum as production lines are completed and customer orders materialize [5] Group 4: Product Progress - The ADAS active perception cleaning system is positioned for future market opportunities, with plans to configure a production capacity of 250,000 sets per year for projects that have reached the designated stage [6] - This product is anticipated to be a significant growth driver in the advanced autonomous driving sector [6] Group 5: Profit Margin and Strategic Planning - The company's gross margin may experience short-term fluctuations due to market conditions, business structure, exchange rate changes, and raw material price variations [7] - Long-term strategies focus on solidifying existing business while pursuing breakthroughs, with an emphasis on diversifying the product matrix and enhancing profitability in the cleaning business [8]

Group 1: Company Overview and Strategy - The meeting was hosted by the Vice President and Secretary of the Board, who expressed gratitude to participating institutional investors and provided an overview of the company's basic situation, development strategy, and recent progress [2] - The company emphasizes compliance with commitment letters and regulations regarding information disclosure for listed companies [2] Group 2: Nuclear Valve Business Operations - The delivery schedule for nuclear valve orders typically involves staggered deliveries over the second and third years after order confirmation, with revenue recognition occurring in phases based on actual delivery progress [3] - Although nuclear valves have a design lifespan of up to 60 years, components may require replacement due to harsh operating conditions, necessitating preventive maintenance and periodic replacements [4] - The company primarily exports nuclear valves through indirect channels, partnering with large domestic enterprises that have overseas engineering contracting qualifications [5][6] Group 3: Market Expansion and Product Development - The company has made significant progress in expanding its export market access and certification scope, laying a solid foundation for obtaining foreign trade orders [7] - The company aims to increase the value of its products in each nuclear unit to over 100 million yuan, with growth expected from expanding product lines and the spare parts market [9] - The company is actively investing in R&D for special valves aimed at advanced nuclear applications, including nuclear fusion power generation [10] Group 4: Production Capacity and Future Outlook - New production capacity projects are currently in the equipment installation phase, with substantial capacity expected to be gradually released starting in early 2026 [11] - The company is experiencing a growing demand for spare parts as the number of operational nuclear units increases, contributing to a stable and sustainable revenue growth source [8] Group 5: Meeting Conclusion - The investor call lasted from 15:00 to 16:00 on December 23, 2025, and there were no significant undisclosed information leaks during the meeting [12]

证券代码：002438 证券简称：江苏神通 江苏神通阀门股份有限公司投资者关系活动记录表 编号：2025-024 | | □特定对象调研 | □分析师会议 | | --- | --- | --- | | 投资者关系活动 | □媒体采访 | □业绩说明会 | | | □新闻发布会 | □路演活动 | | 类别 | □现场参观 | | | | □√其他（电话调研） | | | 参与单位名称及 | | 信达证券、中信建投证券自营、中信资管、六妙星私募、诺安基 | | 人员姓名 | 金、申万菱信基金 | | | 时间 | 2025 年 12 月 23 日 | | | 地点 | 公司会议室 | | | 上市公司接待人 | 副总裁、董事会秘书：章其强先生 | | | 员姓名 | 投资者关系经理：张健先生 | | | 投资者关系活动 | | 机构投资者就公司生产经营情况、未来发展规划和战略等进行沟 | | 主要内容介绍 | 通交流。 | | | 附件清单（如有） | 具体内容详见附件：2025 年 12 月 | 23 日投资者调研会议记录 | | 日期 | 2025 年 12 月 23 日 | | ...

Company Overview - Jiangsu Asia-Pacific Light Alloy Technology Co., Ltd. was established in 2001 and listed on the Shenzhen Stock Exchange in 2011. As of mid-2025, the total assets reached CNY 8.023 billion [2] - The company is a key supplier in the automotive thermal management and lightweight system components materials sector, focusing on high-end aluminum alloy material import substitution and application experience [2] Production Capacity and Development - The company is actively expanding its production capacity in emerging fields such as new energy vehicles, aerospace, industrial thermal management, and robotics [3] - Key projects include: - Annual production of 2 million sets of high-strength aluminum system components for new energy vehicles - Annual production of 12 million lightweight high-performance aluminum profile components for automobiles - Annual production of 14,000 tons of high-efficiency, corrosion-resistant aluminum tubes for household air conditioning [3] Product Offerings Thermal Management - Products include aluminum materials for automotive cabin thermal management systems, such as air conditioning liquid cooling pipes, composite pipes, seamless pipes, and microchannel pipes [4] - The company also provides materials for automotive power system thermal management, meeting high efficiency, low leakage, high pressure resistance, and lightweight requirements [4] Aerospace - The aerospace product line includes high-strength aluminum alloys for aircraft hydraulic, braking, sealing, heat exchange, door, and seat systems [5] - The company has gained certification from major aircraft manufacturers, supporting the domestic aerospace industry's development [5] International Expansion - On July 29, 2025, the company approved the acquisition of 100% equity in Alunited France SAS and Alunited Denmark A/S for €1,533,000, with an additional capital increase of €1,467,000 for operational purposes [6] Profit Distribution - In 2025, the company distributed cash dividends of CNY 2.00 per 10 shares for the 2024 fiscal year, totaling CNY 247,154,648.60, and CNY 1.00 per 10 shares for the first half of 2025, totaling CNY 123,443,231.80 [7] Future Development Strategy - The company aims to capture opportunities in high-end aluminum applications in automotive, aerospace, marine engineering, new energy, and thermal management sectors [7] - Plans include enhancing production capacity, optimizing governance structures, focusing on market trends, and leveraging digitalization for management efficiency [7]